Inspire Medical Systems, Inc. vs Johnson & Johnson — Stock Comparison
Inspire Medical Systems, Inc. (INSP) and Johnson & Johnson (JNJ) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Johnson & Johnson scores ahead of Inspire Medical Systems, Inc. on Q·Score (7.2 vs 6.4 out of 10), led by Sentiment (7.4 vs 3.7) and Valuation (7.3 vs 3.6). Inspire Medical Systems, Inc. scores higher on Health, reflecting stronger balance sheet strength. Analyst consensus targets imply greater upside for JNJ (+7.6%) than for INSP (-19.5%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ elevated valuation at 51× forward P/E.
High-quality business with 26% return on equity and 21% profit margins.
⚠ earnings contracting 1% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
INSP vs JNJ: which stock scores better overall?
Based on Q·Score, Johnson & Johnson (JNJ) scores 7.2/10 versus Inspire Medical Systems, Inc. (INSP) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: INSP or JNJ?
Inspire Medical Systems, Inc. (INSP) scores higher on Growth (6.2/10 vs 5/10). Inspire Medical Systems, Inc. reports revenue growth (1.6% YoY) while Johnson & Johnson reports (6.6% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is INSP or JNJ more attractively valued?
Johnson & Johnson (JNJ) scores higher on Valuation (7.3/10 vs 3.6/10). INSP trades at 50.6× P/E versus JNJ at 19.7×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about INSP vs JNJ?
There are 14 analysts covering INSP with a consensus price target of $51.43, and 22 analysts covering JNJ with a consensus target of $271.73. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: INSP or JNJ?
Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 7.7/10). Net profit margin: INSP at 14.3%, JNJ at 21.5%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: INSP or JNJ?
Inspire Medical Systems, Inc. (INSP) scores higher on Financial Health (9.7/10 vs 6.5/10). Market beta: INSP at 0.67, JNJ at 0.23. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of INSP and JNJ?
Inspire Medical Systems, Inc. (INSP) has a market capitalisation of $1.8B, while Johnson & Johnson (JNJ) has a market cap of $608.4B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do INSP or JNJ pay dividends?
INSP does not currently pay a dividend, while JNJ pays a dividend yield of 2.09%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →